Detalhe da pesquisa
1.
A multicenter phase Ib trial of the histone deacetylase inhibitor entinostat in combination with pembrolizumab in patients with myelodysplastic syndromes/neoplasms or acute myeloid leukemia refractory to hypomethylating agents.
Ann Hematol
; 103(1): 105-116, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38036712
2.
Persisting gaps in M-OUD coverage at post-discharge recovery houses necessitate our continued advocacy.
Subst Abus
; 41(1): 11-13, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31800375
3.
The interleukin-3 receptor CD123 targeted SL-401 mediates potent cytotoxic activity against CD34+CD123+ cells from acute myeloid leukemia/myelodysplastic syndrome patients and healthy donors.
Haematologica
; 103(8): 1288-1297, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29773600
4.
5.
Chronic myeloid leukemia with pure erythroid leukemia blast crisis.
Leuk Lymphoma
; 63(1): 212-216, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34486918
6.
Par-4 overexpression impedes leukemogenesis in the Eµ-TCL1 leukemia model through downregulation of NF-κB signaling.
Blood Adv
; 3(8): 1255-1266, 2019 04 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30987970
7.
MIR142 Loss-of-Function Mutations Derepress ASH1L to Increase HOXA Gene Expression and Promote Leukemogenesis.
Cancer Res
; 78(13): 3510-3521, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29724719